Home    Back

Fulvestrant    (DrugBank: Fulvestrant)

2 diseases
IDDisease name (Link within this page)Number of trials
49Systemic lupus erythematosus0
86Pulmonary arterial hypertension1

49. Systemic lupus erythematosus    [ 827 clinical trials,   638 drugs,   (DrugBank: 168 drugs),   108 drug target genes,   191 drug target pathways]
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 827 trial found

86. Pulmonary arterial hypertension    [ 1,083 clinical trials,   667 drugs,   (DrugBank: 122 drugs),   98 drug target genes,   185 drug target pathways]
Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,083 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02911844
(ClinicalTrials.gov)		April 10, 201719/9/2016Estrogen Receptor Antagonist in Patients With Pulmonary Arterial HypertensionEstrogen Receptor Antagonist in Patients With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionDrug: FulvestrantUniversity of PennsylvaniaNULLCompleted18 YearsN/AFemale5Phase 2United States